OSCR
Oscar Health, Inc.
OSCR has the edge over TKNO overall, supported by stronger fundamentals and lower modeled downside.
TKNO
Alpha Teknova, Inc.
TKNO offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
TKNO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Strong |
TKNO's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
TKNO PE Valuation
TKNO has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
TKNO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect TKNO's losses to shrink, with revenue growing.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over TKNO on earnings quality, reporting a profit while its opponent remains loss making.
TKNO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.28 | +$0.05 |
| Q2 2026 | -$0.30 | +$0.10 |
| Q1 2026 | -$0.31 | +$0.15 |
| Q4 2025 | -$0.32 | +$0.25 |
| Q3 2025 | -$0.33 | +$0.41 |
| Q2 2025 | -$0.40 | +$0.53 |
| Q1 2025 | -$0.46 | +$0.59 |
| Q4 2024 | -$0.57 | +$0.59 |
TKNO is still losing money, but far less than before: $0.28 per share over the past year, against $1.83 at its worst in mid-2023.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over TKNO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over TKNO on profitability, with a higher operating margin.
TKNO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $12.7M | +22% |
| Q2 2026 | $12.2M | +18% |
| Q1 2026 | $11.1M | +13% |
| Q4 2025 | $10M | +7.8% |
| Q3 2025 | $10.5M | +9.2% |
| Q2 2025 | $10.3M | +7% |
| Q1 2025 | $9.8M | +5.4% |
| Q4 2024 | $9.3M | +18% |
TKNO's revenue has grown year over year for nine quarters in a row: $13M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -25% | +13 points |
| Q2 2026 | -24% | +9.2 points |
| Q1 2026 | -39% | +12 points |
| Q4 2025 | -46% | +15 points |
| Q3 2025 | -38% | +39 points |
| Q2 2025 | -33% | +20 points |
| Q1 2025 | -51% | +35 points |
| Q4 2024 | -61% | +77 points |
TKNO's operating margin was −25% last quarter, up 13 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over TKNO on cash generation, producing positive trailing cash flow while its opponent burns cash.
TKNO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.4M | +$969K |
| Q2 2026 | -$596K | +$1.7M |
| Q1 2026 | -$3.6M | +$729K |
| Q4 2025 | -$810K | +$693K |
| Q3 2025 | -$2.4M | +$23K |
| Q2 2025 | -$2.3M | +$645K |
| Q1 2025 | -$4.3M | +$2.4M |
| Q4 2024 | -$1.5M | +$1.7M |
TKNO has burned cash in almost every quarter: −$6M over the past year, against −$10M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
TKNO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +59.6K shares |
| 1 year | +0.3% | +177K shares |
| 3 years | +90% | +25.4M shares |
| 5 years | +106% | +27.6M shares |
TKNO has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
TKNO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | -47.1x | Net Cash |
| Q1 2021 | -0.5x | Net Cash |
| Q4 2020 | -0.5x | Net Cash |
TKNO has more cash than debt.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
TKNO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.0 | Neutral |
| Stochastic | 64.2 | Neutral |
TKNO's weekly RSI is 61 (neutral) and its Stochastic is 64 (neutral).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
TKNO PE vs Healthcare Sector
TKNO has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR is in an uptrend: it's above all five of its weekly moving averages, and 106% above its 200-week average.
TKNO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.02 | 3.4% above |
| 20 week MA | $7.02 | 18% above |
| 50 week MA | $4.94 | 68% above |
| 100 week MA | $5.41 | 53% above |
| 200 week MA | $4.43 | 87% above |
TKNO is in an uptrend: it's above all five of its weekly moving averages, and 87% above its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over TKNO on returns for 2026, with the stronger performance.
TKNO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $25.0 | $20.4 | -19% |
| 2022 | $20.4 | $5.14 | -75% |
| 2023 | $5.14 | $3.73 | -27% |
| 2024 | $3.73 | $8.73 | +134% |
| 2025 | $8.73 | $4.04 | -54% |
| 2026 YTD | $4.04 | $8.29 | +105% |
TKNO's yearly returns have swung widely, from +134% in 2024 to −75% in 2022. It's up 105% so far in 2026.